Helping gynecologic cancer patients with frailty recover function
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests a program to help gynecologic cancer patients who are frail improve their physical function and quality of life during treatment. It aims to see if extra support can help you stay stronger and recover better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are being checked for a newly diagnosed gynecologic cancer (like ovarian, uterine, or cervical cancer).
- You can understand and sign a consent form, or have someone who can help you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding an exercise and activity tracking program can help patients with newly diagnosed gynecologic cancer feel better and handle treatment more easily. You'll wear a Fitbit and get guidance on movement while you go through chemotherapy or surgery.
This study tests a personalized at-home exercise program designed for gynecologic cancer survivors who have finished treatment. The goal is to see if it can help you feel better and improve symptoms.
This trial studies simple “frailty” assessments (tests of strength, memory, and daily functioning) to better predict risk in people with gynecologic cancers who are planning or having surgery. If you qualify, the results may help doctors identify who needs extra support before and after surgery.
This trial tests a personalized exercise and rehabilitation program before cancer treatment to help patients stay stronger and function better. It is designed for people with stage III-IVA gynecologic cancer who are about to start systemic therapy.
This study looks at the emotional and practical support needs of people with gynecologic cancers and their caregivers. It aims to improve support services by understanding what help people need during chemotherapy treatment.
This study follows young adults (ages 15-39) with gynecologic cancers to learn about their outcomes and improve care. By joining, you help researchers understand what treatments work best for people your age.
Hear when a new Malignant Female Reproductive System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.